MARC Record from harvard_bibliographic_metadata

LEADER: 03622nam a2200457 a 4500
001 009405466-5
005 20090713045346.0
008 030131s2003 njua b 001 0 eng
010 $a 2003041669
020 $a1588293114 (alk. paper)
035 0 $aocm51637856
040 $aDLC$cDLC$dDLC
042 $apcc
043 $an-us---
050 00 $aQP277$b.H87 2003
060 00 $a2003 L-793
060 10 $aQS 604$bH9185 2003
082 00 $a612.6/46$221
245 00 $aHuman embryonic stem cells /$cedited by Arlene Y. Chiu and Mahendra S. Rao.
260 $aTotowa, N.J. :$bHumana Press,$cc2003.
300 $axviii, 461 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references and index.
505 0 $aCh. 1. Ethical issues associated with pluripotent stem cells -- Ch. 2. A researcher's guide to federally funded human embryonic stem cell research in the United States -- Ch. 3. Intellectual property of human pluripotent stem cells -- Ch. 4. Embryonal carcinoma cells: The malignant counterparts of ES and EG cells -- Ch. 5. Human pluripotent stem cells from bone marrow -- Ch. 6. Protocols for the isolation and maintenance of human embryonic stem cells -- Ch. 7. Subcloning and alternative methods for the derivation and culture of human embryonic stem cells -- Ch. 8. Diffferentiation of neuroepithelia from human embryonic stem cells -- Ch. 9. Pancreatic differentiation of pluripotent stem cells -- Ch. 10. Human embryonic stem cell-derived -- Ch. 11. Vascular lineage differentiation from human embryonic stem cells -- Ch. 12. Hematopoietic progenitors derived from human embryonic stem cells -- Ch. 13. Human embryonic vs adult stem cells for transplantation therapies -- Ch. 14. Genetic manipulation of human embryonic stem cells -- Ch. 15. Human therapeutic cloning -- Ch. 16. Therapeutic uses of embryonic stem cells -- Ch. 17. Human embryonic stem cells and the Food and Drug Administration: Assuring the safety of novel cellular therapies -- Ch. 18. Studies of a human neuron-like cell line in stroke and spinal cord injury: Preclinical and clinical perspectives.
520 $aA discussion of all the key issues in the use of human pluripotent stem cells for treating degenerative diseases or for replacing tissues lost from trauma. On the practical side, the topics range from the problems of deriving human embryonic stem cells and driving their differentiation along specific lineages, regulating their development into mature cells, and bringing stem cell therapy to clinical trials. Regulatory issues are addressed in discussions of the ethical debate surrounding the derivation of human embryonic stem cells and the current policies governing their use in the United States and abroad, including the rules and conditions regulating federal funding and questions of intellectual property.
650 0 $aEmbryonic stem cells.
650 0 $aHuman embryo.
650 12 $aEmbryonic Structures$xcytology
650 12 $aPluripotent Stem Cells
650 22 $aEmbryo Research
650 22 $aHuman Experimentation
651 2 $aUnited States
650 12 $aEmbryo, Mammalian$xcytology$zUnited States.
650 12 $aPluripotent Stem Cells$zUnited States.
650 22 $aEmbryo Research$zUnited States.
650 22 $aHuman Experimentation$zUnited States.
700 1 $aChiu, Arlene Y.
700 1 $aRao, Mahendra S.
776 08 $iOnline version:$tHuman embryonic stem cells.$dTotowa, N.J. : Humana Press, c2003$w(OCoLC)649844216
776 08 $iOnline version:$tHuman embryonic stem cells.$dTotowa, N.J. : Humana Press, ©2003$w(OCoLC)649844216
988 $a20110914
906 $0DLC